Beruflich Dokumente
Kultur Dokumente
S.N.S
S.N.S
1
Bile
- Secreted by hepatocytes
S.N.S
Bile composition
Cholesterol
Phospholipids Miscellaneous (Pigment, Protein)
(Lecithin)
Bile Salts 0.7%
4% H20
1%
12%
84.3%
S.N.S
2
Bile salts are conjugated with glycine or
taurine to increase their solubility at lower pH
Dehydroxylation Dehydroxylation
Secondary bile salts
S.N.S
2. Cholesterol excretion
a. Bile salts are generated from cholesterol and their
synthesis thus decreases the cholesterol pool
b. Cholesterol is excreted into bile
S.N.S
3
Formation and secretion of bile acids
1. Synthesis (0.3-0.6g) 2. Enterohepatic circulation
(5-10x daily)
ABC transporters
ABCG11 ABCG11
Cholesterol Various proteins located at the
basolateral membrane that mediate
Cyp7a transport of bile acids, cholesterol and
phospholipids into bile
Pool =2-3g
Bile acids
ABCG11
S.N.S
4
The Nuclear
FXR
Bile salts arereceptors
is a sensor of bile FXR
hepatoxic acids
at plays an important
and prevents
high role
bile acid
concentrations
in bile salt metabolism
toxicity
Hepatocyte
Cholesterol
FXR stimulation:
Cyp7a
1. Decreased bile salt
synthesis
Bile
acids 2. Increased bile salt
secretion
FXR
Lowers intracellular
bile acid pool
Synthetic FXR
increasing bile acid
Agonists secretion into bile may
(Moschetta et al, Nat Med 2004)
ABCG11 prevent gallstone formation
S.N.S
Secretion of cholesterol
HDL LDL
SR-BI LDL-R
Synthesis
S.N.S
5
The nuclear receptor LXR is a cholesterol sensor and
lowers intracellular cholesterol levels
Cholesterol
Cholesterol
Cyp7a
LXR LXR stimulation:
Bile 1. Increased bile salt
Bile acids synthesis decreases
acids ABCG5/8 cholesterol
2. Increased
cholesterol secretion
ABCG5/8
S.N.S
S.N.S
6
Excess cholesterol precipitates to form cholesterol
crystals and stones
S.N.S
S.N.S S.N.S
7
Where do gallstone develop?
8
Cholesterol stones:
1 cm
Pigment stones:
- much less common in US than Cholesterol stones
- contain pigment = bilirubin
S.N.S
Main causes
Chronic Hemolysis excess bilirubin
Decreased bilirubin conjugation decreased bilirubin solubility
(cirrhosis, bacterial infections)
S.N.S
9
x-Ray Appearance of Gallstones
Radio-opaque Radioluscent
SUPERSATURATION
STASIS NUCLEATION
10
Factors Favoring Cholesterol Gallstones
• Hepatic Production of Lithogenic Bile
B. Decreased Secretion of Bile Acids
1. Decreased bile salt synthesis despite diminished pool, e.g.
Cyp7a mutations (rare)
2. Decreased bile acid return to liver (ileal resection)
• Gallbladder Factors
1. Stasis (TPN, fasting, progestins)
2. Nucleation (increased mucoproteins)
S.N.S
S.N.S
11
Schematic diagram for the management of gallstone disease
Gallstones
Asymptomatic Symptomatic
Laparoscopic
Cholecystectomy
+/-ERCP
Only if contraindications
for surgery:
Ursodiol •Observation
-Visualize
Good success with biliary tree and stones
small Cholesterol •Ursodiol
Very highpancreatic
recurrenceducts
rate •Possibly emergency
-Extract stones surgery S.N.S
SUMMARY GALLSTONES
12
PANCREAS PHYSIOLOGY
S.N.S
S.N.S
13
Major functional units
ACINUS
Digestive enzyme secretion
(Trypsin, Elastase, Amylase, Lipase )
DUCTULE
Water, bicarbonate secretion
S.N.S
Meal-stimulated secretion
160
140
120 8.0
Ion (mEq/L)
100
80 pH
60
40
7.0
20
0
14
Bicarbonate secretion is regulated through hormonal and neural mechanisms
Gastric phase
Intestinal phase
Secretin
duodenal
pH<4.5 H20, NaHC03 CFTR
pH sensitive Secretin
Secretin-releasing factor S-cells S.N.S
M3-R
Intestinal phase
CCK CCK Digestive
-RF (I-cells) Enzymes
Proteins,
AA, FA
S.N.S
15
Activation of pancreatic enzymes in the intestine
SPINK
Enterokinase
Trypsinogen Trypsin
Trypsinogen Trypsin
Trypsinogen Trypsin
Chymotrypsinogen Chymotrypsin
Proelastase Elastase
2 Mechanisms to prevent autodigestion:
Procarboxypeptidase Carboxypeptidase
-Trypsinogen activation occurs outside
Prophospholipase of the pancreas
Phospholipase
-Pancreatic inhibitor prevents trypsinogen
Procolipase activation
Colipase
S.N.S
PATHOGENESIS OF
PANCREATITIS
S.N.S
16
Classification of pancreatitis
Functional and CHRONIC
EtOH
morphologic changes Outcome:
Pain
Endocrine insufficiency
Exocrine insufficiency
ACUTE RECURRENT
e.g. sludge, SOD
Outcome:
Recovery or death
ACUTE
e.g. stone, EtOH
Outcome:
Time Recovery or death S.N.S
Acute Pancreatitis
- Clinically severe
17
Etiology of Acute Pancreatitis
• Autoimmune
• Drug-induced
• Iatrogenic
Alcoholic • IBD-related
Idiopathic
• Infectious
Other • Inherited
Biliary
• Metabolic
• Neoplastic
• Structural
• Toxic
• Traumatic
• Vascular
S.N.S
1. Blockage of Secretion
2. Activation of Zymogens
in Lysosymes (Cathepsin B) Lysosome
RER
S.N.S
18
Cytokines Play an Important Role in Pancreatic Injury
Systemic
complications
Pancreatic
Pancreatic
Acinar
Acinar Cell
Cell
Cytokine
Insult production
Chemoattraction
and activation
Neutrophil
Neutrophil Macrophage
Macrophage
Inflammation
Cell Death
S.N.S
ICAM-1
IL-1β PAF
TNFα TNFα Endothelin
IL-1β PAF INOS
IL-61 Proinflammatory ICAM-1
S.N.S
19
Local effects of inflammation and pancreas injury
S.N.S
Chronic Pancreatitis
- Chronic disease
S.N.S
20
Etiology of Chronic Pancreatitis
Cystic fibrosis
Other Hereditary pancreatitis
Alcoholic
Hypertriglyceridemia
Idiopathic Autoimmune
Fibrocalcific (Tropical)
S.N.S
Direct toxic
effects
Altered protein
synthesis
Cytotoxic (unfavorable ratio of
lymphocytes trypsinogen vs. inhibitors)
S.N.S
21
Hereditary Pancreatitis
Spink
S.N.S
PANCREATITIS
CLINICAL CONSIDERATONS
S.N.S
22
Laboratory parameters are crucial to establish the
diagnosis of acute pancreatitis
Amylase
Lipase is and
moreLipase
specific
arethan
typically
Amylase
highly
andelevated
remains
in
elevated
Acute for
Pancreatitis
a longer period
Other causes of hyperamylasemia and hyperlipasemia:
Parotitis
S.N.S
If CT is performed within 24h of first symptoms, necrosis may not yet be present
S.N.S
23
PROGNOSIS OF ACUTE PANCREATITIS
Ranson’s severity score & mortality
Admission During first 48h
•• Age
Age >> 55
55 years
years •• Hct
Hct decrease
decrease >10%
>10%
•• WBC
WBC > 16,000 mm
> 16,000 mm33 •• BUN
BUN increase >> 55 mg/dl
increase mg/dl
•• Glucose
Glucose >> 200
200 mg/dl
mg/dl •• Ca2+
Ca 2+ <
< 88 mg/dl
mg/dl Fat necrosis
•• LDH
LDH >> 350
350 IU/L
IU/L •• PaO < 60 mm
PaO22 < 60 mm Hg Hg
•• AST > 120 IU/L
AST > 120 IU/L •• Base
Base deficit
deficit >> 44 mEq/L
mEq/L
Systemic disease •• Negative
Negative fluid
fluid balance
balance >> 6L
6L
100
Most patients with
80 severe pancreatitis
60
%
Mortality 40
20
0 Score
0 to 2 3 to 5 6 to 8 9 to 11 S.N.S
Grey-Turner sign
No epithelial lining
24
Acute Pancreatitis Complications
Infected Necrosis
Treatment
+
Anti
biotic
S.N.S
(EUS)
Amylase and Lipase are often within the normal range!! S.N.S
25
Chronic Pancreatitis: Diagnostic tests
Imaging Functional
Most
ERCP/EUS sensitive Secretin test
CT Less
sensitive Fecal chymotrypsin
Ultrasonogram Serum trypsinogen
Least
Fecal fat
Abdominal x-ray
Blood glucose
S.N.S
26
Chronic Pain and Malabsorption/Malnutrition are the
most common Symptoms of Chronic Pancreatitis
S.N.S
Exogenous
Exogenous
Protease
Protease
Food
Food
Less
pain
CCK
CCK
Exogenous
Exogenous
Proteases
Proteases
degrading
degrading
CCK-RF
CCK-RF
CCK-RF
CCK-RF cell
cell
S.N.S
27
SUMMARY PANCREATITIS
28